The 9 references in paper A. Pavlysh V., A. Kolbin S., A. Kasimova R., А. Павлыш В., А. Колбин С., А. Касимова Р. (2015) “Фармакоэкономический анализ применения оксалиплатина в химиотерапии колоректального рака. Данные реальной клинической практики // PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA” / spz:neicon:pharmacoeconomics:y:2014:i:3:p:26-29

1
Belousov Yu.B. Planning and conduct of clinical trials of medicinal products [Planirovanie i provedenie klinicheskikh issledovanii lekarstvennykh sredstv]. Moscow. 2000; 579 s.
(check this in PDF content)
2
Gan'shina I.P., Barsukov Yu.A. Vestnik RONTs im. N.N. Blokhina RAMN. 2006; 17 (3): 5-11.
(check this in PDF content)
3
Data on the purchase of the St. Petersburg government health care «City Clinical Oncology Dispensary» [Dannye zakupki SanktPeterburgskogo gosudarstvennogo uchrezhdeniya zdravookhraneniya «Gorodskoi klinicheskii onkologicheskii dispanser»]. 2010.
(check this in PDF content)
4
Kaprin A.D., Starinskii V.V., Petrova G.V. Malignancies in 2012 (morbidity and mortality) [Zlokachestvennye novoobrazovaniya v 2012 godu (zabolevaemost' i smertnost')]. Moscow. 2013.
(check this in PDF content)
5
The Ministry of Health of the Russian Federation. No163 order dated 27.05.2011. Industry standard clinical and economic research. General provisions 91500.14.0001-2002. [Ministerstvo Zdravookhraneniya Rossiiskoi Federatsii. Prikaz No163 ot 27.05.2011. Otraslevoi standart kliniko-ekonomicheskogo issledovaniya. Obshchie polozheniya 91500.14.0001-2002].
(check this in PDF content)
6
Yagudina R.I., Kulikov A.Yu., Nguen T. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2011; 4 (1): 7-12.
(check this in PDF content)
7
Gold M., Siegel J.E., Russell L.B., Weinstein M.C. Costeffectiveness in Health and Medicine. New York. 1996. 425 s.
(check this in PDF content)
8
http://www.gks.ru
(check this in PDF content)
9
Walley T., Haycox A., Boland A. Pharmacoeconomics – Elsevier Health Sciences. 2004. 216 s. PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA Pavlysh A.V.1, Kolbin A.S.1,2, Kasimova A.R.1
(check this in PDF content)